Bessemer Group
PAHC icon

Bessemer Group’s Phibro Animal Health PAHC Stock Holding History

Bessemer Group’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.56M Sell
81,384
-125
-0.2% -$5.27K ﹤0.01% 807
2026
Q1 		$4.51M Buy
81,509
+125
+0.2% +$5.95K 0.01% 516
2025
Q4 		$3.04M Buy
81,384
+80,980
+20,045% +$3.29M ﹤0.01% 696
2025
Q3 		$17K Buy
404
+18
+5% +$594 ﹤0.01% 1759
2025
Q2 		$10K Buy
386
+150
+64% +$3.27K ﹤0.01% 1828
2025
Q1 		$5K Hold
236
– – ﹤0.01% 2032
2024
Q4 		$5K Hold
236
– – ﹤0.01% 2011
2024
Q3 		$5K Hold
236
– – ﹤0.01% 1946
2024
Q2 		$4K Hold
236
– – ﹤0.01% 1776
2024
Q1 		$3K Buy
+236
New +$2.83K ﹤0.01% 1883
2023
Q3 		– Sell
-268
Closed -$4K – 2288
2023
Q2 		$4K Hold
268
– – ﹤0.01% 1881
2023
Q1 		$4K Buy
+268
New +$4.09K ﹤0.01% 1691
2020
Q3 		– Sell
-68,863
Closed -$1.81M – 1586
2020
Q2 		$1.81M Buy
68,863
+184
+0.3% +$4.57K 0.01% 515
2020
Q1 		$1.66M Buy
68,679
+14,800
+27% +$362K 0.01% 475
2019
Q4 		$1.34M Buy
53,879
+29,079
+117% +$675K ﹤0.01% 682
2019
Q3 		$529K Sell
24,800
-34,000
-58% -$931K ﹤0.01% 867
2019
Q2 		$1.87M Hold
58,800
– – 0.01% 556
2019
Q1 		$1.94M Buy
58,800
+17,900
+44% +$557K 0.01% 466
2018
Q4 		$1.31M Buy
40,900
+12,300
+43% +$464K 0.01% 509
2018
Q3 		$1.23M Hold
28,600
– – ﹤0.01% 526
2018
Q2 		$1.32M Hold
28,600
– – 0.01% 504
2018
Q1 		$1.14M Buy
28,600
+1,000
+4% +$37K ﹤0.01% 553
2017
Q4 		$925K Sell
27,600
-6,500
-19% -$231K ﹤0.01% 634
2017
Q3 		$1.26M Buy
34,100
+17,300
+103% +$650K 0.01% 589
2017
Q2 		$622K Buy
+16,800
New +$548K ﹤0.01% 804

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bessemer Group's PAHC Position: Q2 2026 in Review

Bessemer Group reduced its Phibro Animal Health (PAHC) stake by 0.15% in Q2 2026, selling an estimated $5.27K and leaving 81,384 shares worth $2.56M. The position accounts for ﹤0.01% of the portfolio, ranked #807.

Bessemer Group first reported a position in PAHC in Q2 2017 and has held it in 25 quarters since. The position peaked at $4.51M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Bessemer Group held 81,384 shares of Phibro Animal Health worth $2.56M as of Q2 2026.
  • Bessemer Group sold 125 Phibro Animal Health shares in Q2 2026, an estimated $5.27K.
  • Phibro Animal Health made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #807 holding.
  • Bessemer Group first reported a position in Phibro Animal Health in Q2 2017 and has held it in 25 quarters since.
  • Bessemer Group's Phibro Animal Health position peaked at $4.51M in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.